Literature DB >> 17895379

Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis.

Sabyasachi Sanyal1, Ann Båvner, Anna Haroniti, Lisa-Mari Nilsson, Thomas Lundåsen, Stefan Rehnmark, Michael Robin Witt, Curt Einarsson, Iannis Talianidis, Jan-Ake Gustafsson, Eckardt Treuter.   

Abstract

Coordinated regulation of bile acid biosynthesis, the predominant pathway for hepatic cholesterol catabolism, is mediated by few key nuclear receptors including the orphan receptors liver receptor homolog 1 (LRH-1), hepatocyte nuclear factor 4alpha (HNF4alpha), small heterodimer partner (SHP), and the bile acid receptor FXR (farnesoid X receptor). Activation of FXR initiates a feedback regulatory loop via induction of SHP, which suppresses LRH-1- and HNF4alpha-dependent expression of cholesterol 7alpha hydroxylase (CYP7A1) and sterol 12alpha hydroxylase (CYP8B1), the two major pathway enzymes. Here we dissect the transcriptional network governing bile acid biosynthesis in human liver by identifying GPS2, a stoichiometric subunit of a conserved corepressor complex, as a differential coregulator of CYP7A1 and CYP8B1 expression. Direct interactions of GPS2 with SHP, LRH-1, HNF4alpha, and FXR indicate alternative coregulator recruitment strategies to cause differential transcriptional outcomes. In addition, species-specific differences in the regulation of bile acid biosynthesis were uncovered by identifying human CYP8B1 as a direct FXR target gene, which has implications for therapeutic approaches in bile acid-related human disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895379      PMCID: PMC2000397          DOI: 10.1073/pnas.0706736104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Identification of a chemical tool for the orphan nuclear receptor FXR.

Authors:  P R Maloney; D J Parks; C D Haffner; A M Fivush; G Chandra; K D Plunket; K L Creech; L B Moore; J G Wilson; M C Lewis; S A Jones; T M Willson
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

2.  Plasticity and expanding complexity of the hepatic transcription factor network during liver development.

Authors:  Irene Kyrmizi; Pantelis Hatzis; Nitsa Katrakili; Francois Tronche; Frank J Gonzalez; Iannis Talianidis
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

3.  Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor.

Authors:  Lulu Farhana; Marcia I Dawson; Mark Leid; Li Wang; David D Moore; Gang Liu; Zeben Xia; Joseph A Fontana
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

4.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Authors:  Takeshi Inagaki; Mihwa Choi; Antonio Moschetta; Li Peng; Carolyn L Cummins; Jeffrey G McDonald; Guizhen Luo; Stacey A Jones; Bryan Goodwin; James A Richardson; Robert D Gerard; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

5.  Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression.

Authors:  Pantelis Hatzis; Irene Kyrmizi; Iannis Talianidis
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

6.  AMF1 (GPS2) modulates p53 transactivation.

Authors:  Y C Peng; F Kuo; D E Breiding; Y F Wang; C P Mansur; E J Androphy
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins.

Authors:  Y C Peng; D E Breiding; F Sverdrup; J Richard; E J Androphy
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner.

Authors:  Yong Li; Mihwa Choi; Kelly Suino; Amanda Kovach; Jennifer Daugherty; Steven A Kliewer; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

9.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

10.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

View more
  39 in total

1.  Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.

Authors:  Shailendra Kumar Dhar Dwivedi; Nidhi Singh; Rashmi Kumari; Jay Sharan Mishra; Sarita Tripathi; Priyam Banerjee; Priyanka Shah; Vandana Kukshal; Abdul Malik Tyagi; Anil Nilkanth Gaikwad; Rajnish Kumar Chaturvedi; Durga Prasad Mishra; Arun Kumar Trivedi; Somali Sanyal; Naibedya Chattopadhyay; Ravishankar Ramachandran; Mohammad Imran Siddiqi; Arun Bandyopadhyay; Ashish Arora; Thomas Lundåsen; Sayee Priyadarshini Anakk; David D Moore; Sabyasachi Sanyal
Journal:  Mol Endocrinol       Date:  2011-04-14

2.  Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice.

Authors:  Yanjun Jiang; Jingling Jin; Polina Iakova; Julio Cesar Hernandez; Nicole Jawanmardi; Emily Sullivan; Grace L Guo; Nikolai A Timchenko; Gretchen J Darlington
Journal:  Mech Ageing Dev       Date:  2013-09-02       Impact factor: 5.432

Review 3.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

4.  GPS2/KDM4A pioneering activity regulates promoter-specific recruitment of PPARγ.

Authors:  M Dafne Cardamone; Bogdan Tanasa; Michelle Chan; Carly T Cederquist; Jaclyn Andricovich; Michael G Rosenfeld; Valentina Perissi
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

Review 5.  Bile Acids as Hormones: The FXR-FGF15/19 Pathway.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

6.  Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.

Authors:  Christophe Gardès; Evelyne Chaput; Andreas Staempfli; Denise Blum; Hans Richter; G Martin Benson
Journal:  J Lipid Res       Date:  2013-02-21       Impact factor: 5.922

7.  Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.

Authors:  Helen B Hartman; Stephen J Gardell; Chris J Petucci; Shuguang Wang; Julie A Krueger; Mark J Evans
Journal:  J Lipid Res       Date:  2009-01-27       Impact factor: 5.922

8.  E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis.

Authors:  Anna Ehrlund; Elin Holter Anthonisen; Nina Gustafsson; Nicolas Venteclef; Kirsten Robertson Remen; Anastasios E Damdimopoulos; Anastasia Galeeva; Markku Pelto-Huikko; Enzo Lalli; Knut R Steffensen; Jan-Ake Gustafsson; Eckardt Treuter
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

Review 9.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

10.  Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation.

Authors:  Dipanjan Chanda; Yuan-Bin Xie; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2010-04-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.